1. HBW Insight

N.Y. City Salon Crusade Includes Investigation Into Nail-Care Chemicals

 
• By Ryan Nelson

New York's Department of Consumer Affairs, which is heading up a large-scale initiative to address reported labor exploitation and health risks in nail salons, has issued a letter to FDA seeking a ban on toluene, formaldehyde and dibutyl phthalate in nail products and intends to investigate manufacturers making "environmental and product claims that may not be valid."

New York City's large-scale advocacy and educational initiative to address labor and health issues in nail salons – covered in a recent investigative series by The New York Times – will include a probe into nail-care chemicals, with a letter already dispatched to FDA calling for a ban on the "toxic trio."

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from HBW Insight

US FDA Finds Banned Cosmetic Ingredient Methylene Chloride In Gel Polish Removers

 
• By Lauren Nardella

Testing conducted by the US Food and Drug Administration has found several cosmetic products on the market that contain high levels of methylene chloride, a banned ingredient.

Euro Q1 Consumer Health Earnings Preview: Haleon, Reckitt, Bayer

 
• By Tom Gallen

Major Europe-based consumer health players Haleon, Reckitt and Bayer feature in this sales and earnings preview, which highlights what to look out for as these three firms report their Q1 2025 results over the coming weeks.

US FDA User Fee Collection Safe In Preliminary Trump 2026 Budget Plan

 
• By Cathy Kelly

The preliminary White House 2026 budget plan cuts agency funding, but not so sharply that user fees are excluded from collection.